Kwality Pharmaceuticals Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|
| Revenue | 111.85 | 116.44 | 85.06 |
| Operating Expense | 87.29 | 89.78 | 66.90 |
| Net Profit | 11.93 | 14.50 | 8.54 |
| Net Profit Margin | 10.67 | 12.45 | 10.04 |
| Earning Per Share | 11.50 | 13.97 | 8.23 |
| EBIDTA | 23.81 | 28.25 | 18.16 |
| Effective Tax Rate | 17.75 | 23.18 | 15.80 |
| Particulars | Jun 2025 |
|---|---|
| Revenue | 111.85 |
| Operating Expense | 87.29 |
| Net Profit | 11.93 |
| Net Profit Margin | 10.67 |
| Earning Per Share | 11.50 |
| EBIDTA | 23.81 |
| Effective Tax Rate | 17.75 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total Revenue Annual | 370.20 | 307.17 | 250.99 |
| Operating Expenses Annual | 289.75 | 240.54 | 190.71 |
| Operating Profit Annual | 82.36 | 61.36 | 46.70 |
| Interest Annual | 9.88 | 10.39 | 6.02 |
| Depreciation | 18.26 | 19.51 | 14.92 |
| Net Profit Annual | 39.89 | 23.98 | 19.47 |
| Tax Annual | 14.34 | 7.48 | 6.29 |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | 370.20 |
| Operating Expenses Annual | 289.75 |
| Operating Profit Annual | 82.36 |
| Interest Annual | 9.88 |
| Depreciation | 18.26 |
| Net Profit Annual | 39.89 |
| Tax Annual | 14.34 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | 1.35 | 1.80 | 7.06 |
| Cash Flow from Operations | 52.77 | 43.35 | 42.19 |
| Cash Flow from Investing | -28.13 | -26.40 | -48.44 |
| Cash Flow from Financing | -14.44 | -17.40 | 0.99 |
| Cash Flow at the End | 11.55 | 1.35 | 1.80 |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | 1.35 |
| Cash Flow from Operations | 52.77 |
| Cash Flow from Investing | -28.13 |
| Cash Flow from Financing | -14.44 |
| Cash Flow at the End | 11.55 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| PBDIT Margin (%) | 22.25 | 22.29 | 25.41 |
| PBIT Margin (%) | 17.32 | 15.94 | 19.46 |
| PBT Margin (%) | 15.57 | 14.41 | 16.52 |
| Net PROFIT Margin (%) | 10.78 | 7.81 | 7.76 |
| Return On Networth / Equity (%) | 16.27 | 13.74 | 16.56 |
| Return On Networth /Employed (%) | 18.29 | 15.90 | 18.47 |
| Return On Assets (%) | 11.31 | 7.73 | 7.37 |
| Total Debt / Equity (X) | 0.43 | 0.44 | 0.38 |
| Asset Turnover Ratio (%) | 1.05 | 0.99 | 0.95 |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | 22.25 |
| PBIT Margin (%) | 17.32 |
| PBT Margin (%) | 15.57 |
| Net PROFIT Margin (%) | 10.78 |
| Return On Networth / Equity (%) | 16.27 |
| Return On Networth /Employed (%) | 18.29 |
| Return On Assets (%) | 11.31 |
| Total Debt / Equity (X) | 0.43 |
| Asset Turnover Ratio (%) | 1.05 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Fixed Assets Annual | 144.47 | 138.18 | 119.57 |
| Total Current Assets Annual | 284.90 | 243.38 | 207.52 |
| Non Current Assets Annual | 165.82 | 154.19 | 149.06 |
| Total Shareholders Funds Annual | 265.84 | 225.95 | 202.03 |
| Total Assets Annual | 450.72 | 397.57 | 356.58 |
| Particulars | Mar 2025 |
|---|---|
| Fixed Assets Annual | 144.47 |
| Total Current Assets Annual | 284.90 |
| Non Current Assets Annual | 165.82 |
| Total Shareholders Funds Annual | 265.84 |
| Total Assets Annual | 450.72 |
EPS (INR)
Expected
11.49
Reported
11.49
Surprise
0.00%
Mar 2025
EPS beaten by 0.00%
Dec 2024
EPS beaten by -0.07%
Sep 2024
EPS beaten by -0.12%
